Chan Soon-Shiong Nanthealth Foundation is located in El Segundo, CA. The organization was established in 2012. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Chan Soon-Shiong Nanthealth Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE SPECIFIC AND PRIMARY PURPOSE OF THIS ORGANIZATION IS TO ENGAGE IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ORGANIZATION IS DIRECTLY ENGAGED IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH VARIOUS CLINICAL SETTINGS AND HOSPITALS. INITIALLY, THE ORGANIZATION WAS ENGAGED IN A JOINT EFFORT WITH PROVIDENCE SAINT JOHN'S HEALTH CENTER TO CONDUCT RESEARCH AND DEVELOPMENT OF PERSONALIZED MOLECULAR MEDICAL THERAPIES FOR THE TREATMENT OF UNMET MEDICAL NEEDS. CURRENTLY, THE ORGANIZATION IS ENGAGED IN JOINT EFFORTS WITH WINDBER HOSPITAL AND JOHNS HOPKINS UNIVERSITY TO CONDUCT PARALLEL RESEARCH AND DEVELOPMENT. THE ORGANIZATION PROVIDES FUNDING, DATA AND EXPERTISE AND PERFORMS SUPPORT SERVICES INCLUDING, WITHOUT LIMITATION, CUSTOM ENGINEERING, REGULATORY AND MEDICAL SUPPORT SERVICES FOR EACH PROJECT CONDUCTED THROUGH ITS JOINT EFFORTS WITH WINDBER HOSPITAL AND JOHNS HOPKINS UNIVERSITY. THE ORGANIZATION ALSO PLANS TO CONDUCT MEDICAL RESEARCH PROJECTS IN COLLABORATION WITH VARIOUS UNIVERSITIES, PARTICULARLY RESEARCH PROJECTS LED BY FACULTY OF THE UNIVERSITY OF CALIFORNIA AND PARTNER INSTITUTIONS. THE ORGANIZATION WILL ANNUALLY EXPEND FUNDS EQUAL TO 3.5% OR MORE OF THE FAIR MARKET VALUE OF ITS ENDOWMENT FOR THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH OR WILL DEVOTE MORE THAN ONE HALF OF ITS ASSETS TO THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH. ON 6/23/2020, A FINAL REPORT WAS ISSUED TO THE ORGANIZATION WITH RESPECT TO RESEARCH CONDUCTED BY MARK KELLY, M.D. REGARDING CERTAIN SIGNIFICANT ASPECTS OF UROLOGICAL ONCOLOGY, PARTICULARLY, THE TREATMENT AND MANAGEMENT OF PROSTATE CANCER. THE RESEARCH WAS INITIATED BY AN AGREEMENT MADE AND EFFECTIVE AS OF OCTOBER 15, 2018. A STEERING COMMITTEE WAS ESTABLISHED TO OVERSEE THE RESEARCH PROJECT AND QUARTERLY MEETINGS WERE HELD BY AND BETWEEN MARK KELLY, M.D. AND THE MEMBERS OF THE STEERING COMMITTEE DURING THE TERM. DR. KELLYS RESEARCH HOPES TO DETERMINE WHETHER MRIS AND OTHER BIOMARKERS CAN BE USED TO IDENTIFY WHICH PATIENTS WITH ELEVATED PSA LEVELS CAN BE TREATED WITH CRYOABLATION TO AVOID ADVERSE SIDE-EFFECTS OF OTHER LESS LOCALIZED COURSES OF TREATMENT.
THE ORGANIZATION IS CONDUCTING AND HOSTING AN ANNUAL HEALTH SUMMIT, CALLED "BREAKTHROUGHS IN MEDICINE," TO EXPLORE, ENGAGE AND DISCUSS CURRENT ISSUES AT THE INTERSECTION OF TECHNOLOGY AND HEALTHCARE, INCLUDING THROUGH ROUNDTABLE DISCUSSIONS. BREAKTHROUGHS IN MEDICINE IS AN EXCLUSIVE EVENT WITH LEADERS, INNOVATORS, INFLUENCERS AND VISIONARIES IN THE INDUSTRY IN ATTENDANCE. THE ORGANIZATION WILL ANNUALLY EXPEND FUNDS EQUAL TO 3.5% OR MORE OF THE FAIR MARKET VALUE OF ITS ENDOWMENT FOR THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH OR WILL DEVOTE MORE THAN ONE HALF OF ITS ASSETS TO THE CONTINUOUS CONDUCT OF MEDICAL RESEARCH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Phillip B Gordon Director Of Govt. Relations | Officer | 40 | $298,680 |
Patrick Soon-Shiong President, Director | OfficerTrustee | 1 | $0 |
Michele B Soon-Shiong Treasurer, Director | OfficerTrustee | 1 | $0 |
Leonard Shapiro Director, Secretary | OfficerTrustee | 0 | $0 |
Michael Sitrick Director | Trustee | 1 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Rodriguez Horii Choi Cafferata Legal | 6/29/18 | $238,989 |
Tichenor Thorp Architecture/design | 6/29/18 | $366,264 |
Cdw Direct Llc Equipment | 6/29/18 | $464,721 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $0 |
Investment income | $55,653 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $8,028 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $63,681 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $276,854 |
Compensation of current officers, directors, key employees. | $276,854 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $30,850 |
Payroll taxes | $13,420 |
Fees for services: Management | $0 |
Fees for services: Legal | $50,414 |
Fees for services: Accounting | $38,994 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $11,717 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $1,657 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $5,996 |
Insurance | $38,313 |
All other expenses | $10,432 |
Total functional expenses | $483,866 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,060,813 |
Savings and temporary cash investments | $297,687 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $34,000 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $45,859 |
Net Land, buildings, and equipment | $71,990 |
Investments—publicly traded securities | $2,548,269 |
Investments—other securities | $20,857,750 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $24,916,368 |
Accounts payable and accrued expenses | $82,872 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $5,577 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $1,666 |
Total liabilities | $90,115 |
Net assets without donor restrictions | $24,826,253 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $24,916,368 |
Over the last fiscal year, Chan Soon-Shiong Nanthealth Foundation has awarded $2,645,305 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Independence, OH PURPOSE: RESEARCH ON MOLECULAR DIAGNOSTIC/PROGNOSTIC BIOMARKERS | $2,500,000 |
Baltimore, MD PURPOSE: MEDICAL RESEARCH | $145,305 |
Organization Name | Assets | Revenue |
---|---|---|
Translational Genomics Research Institute Phoenix, AZ | $224,233,974 | $175,687,790 |
J David Gladstone Institutes San Francisco, CA | $318,407,379 | $84,274,665 |
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Torrance, CA | $198,389,340 | $88,849,610 |
Veterans Medical Research Foundation Of Sd San Diego, CA | $7,321,086 | $16,367,755 |
Huntington Medical Research Institutes Pasadena, CA | $82,259,720 | $16,674,865 |
International Anesthesia Research Society San Francisco, CA | $39,176,119 | $7,595,072 |
California Heart Center Foundation Beverly Hills, CA | $198,494 | $2,474,527 |
House Institute Foundation Los Angeles, CA | $6,887,696 | $1,568,325 |
Fanconi Anemia Research Fund Inc Eugene, OR | $8,601,390 | $4,056,234 |
The Gpcr Institute San Marcos, CA | $1,290,580 | $0 |
Musculoskeletal-Orthopedic Research And Education Foundation Phoenix, AZ | $591,829 | $1,272,150 |
Terasaki Innovation Center Inc Glendale, CA | $6,320,184 | $1,253,217 |